| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |